Cesium carbonate → HCID 58237948, compound
Reaction equation
[CH2:1]([C@:4]1([C:28]2[CH:33]=[CH:32][C:31]([F:34])=[CH:30][CH:29]=2)[CH2:9][CH2:8][N:7]([C@H:10]([C:12]2[CH:17]=[CH:16][C:15](B3OC(C)(C)C(C)(C)O3)=[CH:14][CH:13]=2)[CH3:11])[C:6](=O)[CH2:5]1)[CH:2]=[CH2:3].Br[C:36]1[CH:37]=[CH:38][C:39](=[O:43])[N:40]([CH3:42])[CH:41]=1.C([O-])([O-])=[O:45].[Cs+].[Cs+]>O1CCOCC1.CCOC(C)=O>[CH2:1]([C@:4]1([C:28]2[CH:29]=[CH:30][C:31]([F:34])=[CH:32][CH:33]=2)[CH2:9][CH2:8][N:7]([C@H:10]([C:12]2[CH:13]=[CH:14][C:15]([C:36]3[CH:37]=[CH:38][C:39](=[O:43])[N:40]([CH3:42])[CH:41]=3)=[CH:16][CH:17]=2)[CH3:11])[C:6](=[O:45])[CH2:5]1)[CH:2]=[CH2:3]Participants
Procedure
A mixture of (S)-4-allyl-4-(4-fluorophenyl)-1-((S)-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)piperidin-2-one (120 mg, 0.260 mmol), 5-bromo-1-methylpyridin-2(1H)-one (80 mg, 0.31 mmol), PdCl2(Ph3P)2 (12 mg) □ Cs2CO3 (0.4 mL, 0.8 mmol□ in 1,4-dioxane (3 mL) was heated to reflux for 2 h. The mixture was diluted with EtOAc, and washed with water. The organic phase was separated, and concentrated to give the product, which was purified by TLC to afford 5-(4-((S)-1-((S)-4-allyl-4-(4-fluorophenyl)-2-oxopiperidin-1-yl)ethyl)phenyl)-1-methylpyridin-2(1H)-one (45 mg, 39%). 1H NMR (CDCl3): δ 1.42 (t, 3H), 1.91 (m, 1H), 2.03 (m, 1H), 2.24 (m, 2H), 2.39 (m, 1H), 2.49 (d, 1H), 2.96 (m, 2H), 3.49 (s, 3H), 4.92 (m, 2H), 5.38 (m, 1H), 5.99 (m, 1H), 6.11 (m, 1H) □ 6.52 (m, 1H) □ 6.62 (m, 1H), 6.89 (m, 4H), 7.11 (m, 3H), 7.23 (m, 2H), 7.32 (m, 1H), 7.49 (m, 1H).
Workup
- temperaturewas heated
- temperatureto reflux for 2 h
- washwashed with water
- customThe organic phase was separated
- concentrationconcentrated
- customto give the product, which
- customwas purified by TLC
Sources & evidence
- ORD record
- ord-823429e98c7c4a60aa0f9eb7ea5eb494
- Source dataset
- uspto-grants-2014_03
- Patent number
- US08680281B2
Reaction notes
Loading…